Sarepta Therapeutics, Inc. (SRPT) income statement
SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3087% below fair value
$13.33−0.84 (-5.93%)
Close on Nov 20, 2026Market cap $1.41BP/E –Yield –
Sarepta Therapeutics, Inc. financial ratios
See a number that looks wrong?